Results 41 to 50 of about 32,704 (143)

Global Molecular Epidemiology of Respiratory Syncytial Virus from the 2017−2018 INFORM-RSV Study

Journal of Clinical Microbiology, 2020
Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infection among infants and young children, resulting in annual epidemics worldwide.
D. Tabor, F. Fernandes, A. Langedijk, Deidre Wilkins, R. Lebbink, A. Tovchigrechko, A. Ruzin, L. Kragten-Tabatabaie, Hong Jin, M. Esser, L. Bont, M. Abram, Christina Anouk Marco C. Joanne G. Frank E.J. Marije P. Anne Naaktgeboren Evers Viveen Wildenbeest Coenjaerts H   +12 more
semanticscholar   +1 more source

Antiviral and Immunomodulatory Activity of Silver Nanoparticles in Experimental RSV Infection

Viruses, 2019
Respiratory syncytial virus (RSV) is an important etiological agent of respiratory infection in children for which no specific treatment option is available.
Dorothea R. Morris, M. Ansar, J. Speshock, T. Ivanciuc, Y. Qu, A. Casola, R. Garofalo   +6 more
semanticscholar   +1 more source

A multifaceted approach to RSV vaccination [PDF]

Human Vaccines & Immunotherapeutics, 2018
Respiratory Syncytial Virus (RSV) is the leading cause of pneumonia and bronchiolitis in infants, resulting in significant morbidity and mortality worldwide. In addition, RSV infections occur throughout different ages, thus, maintaining the virus in circulation, and increasing health risk to more susceptible populations such as infants, the elderly ...
Marina S. Boukhvalova, Trudy G. Morrison, Stefanie N. Vogel, Jorge C. G. Blanco   +3 more
openaire   +3 more sources

The role of viral co-infections in the severity of acute respiratory infections among children infected with respiratory syncytial virus (RSV): A systematic review and meta-analysis

Journal of Global Health, 2020
Background Respiratory syncytial virus (RSV) is the predominant viral cause of childhood pneumonia. Little is known about the role of viral-coinfections in the clinical severity in children infected with RSV.
You Li, P. Pillai, F. Miyake, H. Nair
semanticscholar   +1 more source

Respiratory Syncytial Virus (RSV) Neutralizing Antibodies at Birth Predict Protection from RSV Illness in Infants in the First 3 Months of Life

Clinical Infectious Diseases, 2020
Background Respiratory syncytial virus (RSV) is a leading cause of viral pneumonia and bronchiolitis during the first 6 months of life. Placentally transferred antibodies can prevent severe RSV illness, and maternal immunization may reduce illness in ...
A. Buchwald, B. Graham, A. Traoré, F. Haidara, Man Chen, Kaitlyn M. Morabito, Bob C. Lin, S. Sow, M. Levine, M. Pasetti, Milagritos D. Tapia   +10 more
semanticscholar   +1 more source

Severe Rhabdomyolysis Associated With RSV [PDF]

Open Forum Infectious Diseases, 2017
AbstractSevere rhabdomyolysis is associated with morbidity and mortality. We report on a previously well male who developed severe rhabdomyolysis, sepsis, and multi-organ failure. The patient made a complete recovery. Extensive microbiological testing was only positive for RSV, making this the first reported case of adult RSV-related rhabdomyolysis in ...
Bender, J, Chew, R, Bin Lin, B, Athan, E
openaire   +3 more sources

Update on current views and advances on RSV infection (Review)

International Journal of Molecular Medicine, 2020
Respiratory syncytial virus (RSV) infection represents an excellent paradigm of precision medicine in modern paediatrics and several clinical trials are currently performed in the prevention and management of RSV infection.
I. Mammas, S. Drysdale, B. Rath, M. Theodoridou, G. Papaioannou, Alexia Papatheodoropoulou, E. Koutsounaki, C. Koutsaftiki, Eleftheria Kozanidou, Vassilis Achtsidis, Paraskevi Korovessi, G. Chrousos, D. Spandidos   +12 more
semanticscholar   +1 more source

Respiratory syncytial virus (RSV): a scourge from infancy to old age

Thorax, 2019
Respiratory syncytial virus (RSV) is the most common single cause of respiratory hospitalisation of infants and is the second largest cause of lower respiratory infection mortality worldwide.
J. Coultas, R. Smyth, P. Openshaw
semanticscholar   +1 more source

Role of Type I Interferon (IFN) in the Respiratory Syncytial Virus (RSV) Immune Response and Disease Severity

Frontiers in Immunology, 2019
Respiratory syncytial virus (RSV) is the most common cause of lower respiratory tract disease in children
Diego R. Hijano, Luan D. Vu, L. Kauvar, R. Tripp, F. Polack, S. Cormier   +5 more
semanticscholar   +1 more source

A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein

Nature Communications, 2019
Respiratory syncytial virus (RSV) infection is the leading cause of hospitalization and infant mortality under six months of age worldwide; therefore, the prevention of RSV infection in all infants represents a significant unmet medical need.
Aimin Tang, Zhifeng Chen, K. Cox, H. Su, Cheryl Callahan, A. Fridman, Lan Zhang, Sangita Patel, P. Cejas, Ryan Swoyer, Sinoeun Touch, Michael P. Citron, Dhanasekaran Govindarajan, Bin Luo, M. Eddins, J. Reid, S. Soisson, Jennifer D Galli, Dai Wang, Zhiyun Wen, G. Heidecker, D. Casimiro, D. Distefano, K. Vora   +23 more
semanticscholar   +1 more source